Grant: China-Canada Joint Health Research Initiative
University of Toronto
$150,000.00
Expression of the Hepatic Glucokinase Gene in the Progression and Treatment of Diabetes
EF 2009-10
Résumé
Diabetes is characterized by the loss of control of blood sugar levels. Diabetes is a complex disease with many causes, both genetic and environmental. The liver has a primary role in maintaining proper blood sugar levels as it is a major site of production of glucose, when blood levels are low, and storing excess levels when blood levels are high. Both high and low levels of blood glucose have serious health consequences. The enzyme glucokinase is the key gatekeeper of glucose metabolism in liver cells as it regulates the production of glycogen and metabolism of glucose. Glucokinase gene expression and enzymatic activity are carefully regulated so that it is only active when there is excess glucose, but in Diabetes the regulation of glucokinase is impaired, thus the uptake of glucose by liver cells is reduced. Activators of glucokinase enzymatic function have been identified and have promise in the treatment of Diabetes. Unfortunately, glucokinase also functions at other sites in the body, and activation of glucokinase function at these sites may have negative health impacts, thus efforts are underway to identify mechanisms that could lead to the liver-specific enhancement of glucokinase function. We propose to investigate mechanisms that regulate the expression, as well as the consequences of impaired regulation, of the glucokinase gene in the liver. An understanding of the mechanisms that regulate glucokinase gene expression, as well as genes and enzymes miss-regulated by glucokinase deficiency, should allow the development of alternate strategies to treat Diabetes.
Programme
China-Canada Joint Health Research Initiative
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
202701
Name
Irwin David M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
National Natural Science Foundation of China (Haidian, Beijing)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
China-Canada Joint Health Research Initiative - Grants Program
Projecttitle
Expression of the Hepatic Glucokinase Gene in the Progression and Treatment of Diabetes
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
China-Canada Joint Health Research Initiative
Keyworddelim
Diabetes; Gene Expression; Glucokinase; Liver
Abstract
Diabetes is characterized by the loss of control of blood sugar levels. Diabetes is a complex disease with many causes, both genetic and environmental. The liver has a primary role in maintaining proper blood sugar levels as it is a major site of production of glucose, when blood levels are low, and storing excess levels when blood levels are high. Both high and low levels of blood glucose have serious health consequences. The enzyme glucokinase is the key gatekeeper of glucose metabolism in liver cells as it regulates the production of glycogen and metabolism of glucose. Glucokinase gene expression and enzymatic activity are carefully regulated so that it is only active when there is excess glucose, but in Diabetes the regulation of glucokinase is impaired, thus the uptake of glucose by liver cells is reduced. Activators of glucokinase enzymatic function have been identified and have promise in the treatment of Diabetes. Unfortunately, glucokinase also functions at other sites in the body, and activation of glucokinase function at these sites may have negative health impacts, thus efforts are underway to identify mechanisms that could lead to the liver-specific enhancement of glucokinase function. We propose to investigate mechanisms that regulate the expression, as well as the consequences of impaired regulation, of the glucokinase gene in the liver. An understanding of the mechanisms that regulate glucokinase gene expression, as well as genes and enzymes miss-regulated by glucokinase deficiency, should allow the development of alternate strategies to treat Diabetes.
Competitiondate
201003
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Irwin, David M; Tan, Huanran
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $150,000~ $0~